S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
3 Aerospace Stocks Set to Fly in 2021
Coinbase Will Be The Hottest IPO Of 2021
3 Small Cap Dividend Stocks with Growth Prospects
Wait For a Better Price Before Placing a Bet On Churchill Downs
Guardion Health Sciences Stock Needs to Give Investors More Than Survival
World shares skid, US futures turn higher after Wall St rout
Vaccination 'passports' may open society, but inequity looms
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
3 Aerospace Stocks Set to Fly in 2021
Coinbase Will Be The Hottest IPO Of 2021
3 Small Cap Dividend Stocks with Growth Prospects
Wait For a Better Price Before Placing a Bet On Churchill Downs
Guardion Health Sciences Stock Needs to Give Investors More Than Survival
World shares skid, US futures turn higher after Wall St rout
Vaccination 'passports' may open society, but inequity looms
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
3 Aerospace Stocks Set to Fly in 2021
Coinbase Will Be The Hottest IPO Of 2021
3 Small Cap Dividend Stocks with Growth Prospects
Wait For a Better Price Before Placing a Bet On Churchill Downs
Guardion Health Sciences Stock Needs to Give Investors More Than Survival
World shares skid, US futures turn higher after Wall St rout
Vaccination 'passports' may open society, but inequity looms
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
3 Aerospace Stocks Set to Fly in 2021
Coinbase Will Be The Hottest IPO Of 2021
3 Small Cap Dividend Stocks with Growth Prospects
Wait For a Better Price Before Placing a Bet On Churchill Downs
Guardion Health Sciences Stock Needs to Give Investors More Than Survival
World shares skid, US futures turn higher after Wall St rout
Vaccination 'passports' may open society, but inequity looms
Log in
NYSEARCA:CN

Xtrackers MSCI All China Equity ETF Stock Forecast, Price & News

$47.71
-0.50 (-1.04 %)
(As of 02/26/2021 12:00 AM ET)
Add
Today's Range
$47.63
Now: $47.71▼
$47.81
50-Day Range
$46.75
MA: $49.82▼
$53.31
52-Week Range
$28.00
Now: $47.71▼
$53.32
Volume2,773 shs
Average Volume3,078 shs
Market Capitalization$33.40 million
P/E RatioN/A
Dividend Yield0.72%
BetaN/A

Basic Details

Issuer DWS
Fund NameXtrackers MSCI All China Equity ETF
Tax ClassificationRegulated Investment Company
SymbolNYSEARCA:CN
Inception Date4/30/2014
Fund ManagerBryan Richards, Patrick Dwyer, Navid Sohrabi, Shlomo Bassous, Charlotte Cipolletti
WebN/A
PhoneN/A

Fund Focus

Asset ClassEquity
BenchmarkMSCI China All Shares Index
CategoryBroad Equity
FocusBroad Equity
Development LevelEmerging Markets
RegionAsia-Pacific

Fund Statistics

Assets Under Management$25.08 million
Average Daily Volume$900.50
Discount/Premium0.09%

ETF Expenses

Management Fee0.60%
Other Expenses0.22%
Total Expenses0.82%
Fee Waiver-0.32%
Net Expenses0.50%

Administrator, Advisor and Custodian

AdministratorThe Bank of New York Mellon Corporation
AdvisorDBX Advisors LLC
CustodianThe Bank of New York Mellon Corporation
DistributorALPS Distributors, Inc.
Transfer AgentThe Bank of New York Mellon Corporation
Trustee
Lead Market MakerJane Street

Geographic Exposure of CN

Currency Exposure of CN

Sector Exposure of CN

Industry Exposure of CN

$47.71
-0.50 (-1.04 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CN News and Ratings via Email

Sign-up to receive the latest news and ratings for CN and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Xtrackers MSCI All China Equity ETF (NYSEARCA:CN) Frequently Asked Questions

What stocks does MarketBeat like better than Xtrackers MSCI All China Equity ETF?

Wall Street analysts have given Xtrackers MSCI All China Equity ETF a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Xtrackers MSCI All China Equity ETF wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has Xtrackers MSCI All China Equity ETF's stock been impacted by COVID-19 (Coronavirus)?

Xtrackers MSCI All China Equity ETF's stock was trading at $33.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, CN stock has increased by 44.5% and is now trading at $47.7095.
View which stocks have been most impacted by COVID-19.

Is Xtrackers MSCI All China Equity ETF a good dividend stock?

Xtrackers MSCI All China Equity ETF pays an annual dividend of $0.35 per share and currently has a dividend yield of 0.72%.
View Xtrackers MSCI All China Equity ETF's dividend history.

What other stocks do shareholders of Xtrackers MSCI All China Equity ETF own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Xtrackers MSCI All China Equity ETF investors own include Phillips 66 (PSX), Onex (ONEX), BlackPearl Resources (PXX), The Toronto-Dominion Bank (TD.TO) (TD), Brookfield Property Partners (BPY), Brookfield Infrastructure Partners (BIP), Alibaba Group (BABA), BAE Systems (BA), ARC Resources Ltd. (ARX.TO) (ARX) and Alliance Resource Partners (ARLP).

What is Xtrackers MSCI All China Equity ETF's stock symbol?

Xtrackers MSCI All China Equity ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "CN."

How do I buy shares of Xtrackers MSCI All China Equity ETF?

Shares of CN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Xtrackers MSCI All China Equity ETF's stock price today?

One share of CN stock can currently be purchased for approximately $47.71.

How much money does Xtrackers MSCI All China Equity ETF make?

Xtrackers MSCI All China Equity ETF has a market capitalization of $33.40 million.


This page was last updated on 2/27/2021 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.